Strontium ranelate and alendronate have differing effects on distal tibia bone microstructure in women with osteoporosis

Rheumatology International

Volumn 30, Issue 10, 2010, Pages 1341-1348

  Rizzoli, René ^a   Laroche, Michel ^b   Krieg, Marc Antoine ^c   Frieling, Isolde ^d   Thomas, Thierry ^e   Delmas, Pierre ^f   Felsenberg, Dieter ^g  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^b CHU RANGUEIL   (France)

^c LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^d Osteoporosezentrum   (Germany)

^e UNIVERSITY HOSPITAL OF SAINT ETIENNE   (France)

^f EDOUARD HERRIOT HOSPITAL   (France)

^g CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Biochemical markers; Bone mineral density; Cortical bone; Microstructure; Trabecular bone

Indexed keywords

ALENDRONIC ACID; CALCIUM; PLACEBO; STRONTIUM RANELATE; VITAMIN D; BONE DENSITY CONSERVATION AGENT; ORGANOMETALLIC COMPOUND; THIOPHENE DERIVATIVE;

ABDOMINAL PAIN; ADULT; ARTICLE; BONE DENSITY; BONE MINERAL; BONE STRUCTURE; BONE TURNOVER; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DENSITY; DOUBLE BLIND PROCEDURE; DRUG DOSE INCREASE; DRUG EFFECT; DRUG EFFICACY; FEMALE; HIP; HUMAN; MAJOR CLINICAL STUDY; OSTEOPOROSIS; PEPTIC ULCER; POSTMENOPAUSE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SPINE; TIBIA; VOLUMETRY; X RAY; BONE DEVELOPMENT; COMPUTER ASSISTED TOMOGRAPHY; DRUG EFFECTS; FEMUR NECK; FRACTURES, BONE; METABOLISM; MIDDLE AGED; OSTEOPOROSIS, POSTMENOPAUSAL; PATHOLOGY; PHYSIOLOGY; RADIOGRAPHY;

ALENDRONATE; BONE DENSITY; BONE DENSITY CONSERVATION AGENTS; FEMALE; FEMUR NECK; FRACTURES, BONE; HIP JOINT; HUMANS; MIDDLE AGED; ORGANOMETALLIC COMPOUNDS; OSTEOGENESIS; OSTEOPOROSIS, POSTMENOPAUSAL; SPINE; THIOPHENES; TIBIA; TOMOGRAPHY, X-RAY COMPUTED;

EID: 77955559627     PISSN: 01728172     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00296-010-1542-y     Document Type: Article

References (29)

1. A Parfitt CH Mathews AR Villanueva M Kleerekoper B Frame DS Rao 1983 Relationships between surface, volume and thickness of iliac trabecular bone in aging and in osteoporosis. Implications for the microanatomic and cellular mechanisms of bone loss J Clin Invest 72 1396 1409 10.1172/JCI111096 1:STN:280:DyaL2c%2FjtlWlug%3D%3D 6630513
2. E Seeman PD Delmas 2006 Bone quality-the material and structural basis of bone strength and fragility N Engl J Med 354 21 2250 2261 10.1056/NEJMra053077 1:CAS:528:DC%2BD28XkvVShsbw%3D 16723616
3. PD Delmas 2002 Treatment of postmenopausal osteoporosis Lancet 359 9322 2018 2026 10.1016/S0140-6736(02)08827-X 1:CAS:528:DC%2BD38XksFKkt7g%3D 12076571 (Pubitemid 34663722)
4. S Boutroy M Bouxsein F Munoz P Delmas 2005 In vivo assessment of trabecular bone microarchitecture by high resolution peripheral quantitative computed tomography J Clin Endocrinol Metab 90 6508 6515 10.1210/jc.2005-1258 1:CAS:528:DC%2BD2MXhtlaltLzI 16189253 (Pubitemid 41759306)
5. A Laib T Hildebrand HJ Haüselmann P Rüegsegger 1997 Ridge number density: a new parameter for in vivo bone structure analysis Bone 21 6 541 546 10.1016/S8756-3282(97)00205-6 1:STN:280:DyaK1c%2FptVWisg%3D%3D 9430245 (Pubitemid 28029698)
6. A Laib P Rüegsegger 1999 Calibration of trabecular bone structure measurements of in vivo three-dimensional peripheral quantitative computed tomography with 28-microm-resolution microcomputed tomography Bone 24 1 35 39 10.1016/S8756-3282(98)00159-8 1:STN:280:DyaK1M7htlyhsg%3D%3D 9916782 (Pubitemid 28546704)
7. E Seeman 2007 Is a change in bone mineral density a sensitive and specific surrogate of anti-fracture efficacy? Bone 41 3 308 317 10.1016/j.bone.2007.06.010 1:STN:280:DC%2BD2svntlaqtw%3D%3D 17644058 (Pubitemid 47199158)
8. UA Liberman SR Weiss J Bröll, et al. 1995 Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis, The Alendronate Phase III Osteoporosis Treatment Study Group N Engl J Med 333 22 1437 1443 10.1056/NEJM199511303332201 1:CAS:528: DyaK28XkslehtA%3D%3D 7477143
9. SE Papapoulos 2008 Bisphosphonates: how do they work? Best Pract Res Clin Endocrinal Metab 22 5 831 847 10.1016/j.beem.2008.07.001 1:CAS:528: DC%2BD1cXhsVWmsbnJ
10. RG Russel N Watts F Ebetino M Rogers 2008 Mechanisms of action of bisphosphonates: similarities and differences and their potential influence on clinical efficacy Osteoporos Int 19 733 759 10.1007/s00198-007-0540-8
11. PM Chavassieux ME Arlot C Reda L Wei J Yates PJ Meunier 1997 Histomorphometric assessment of the long-term effects of alendronate on bone quality and remodelling in patients with osteoporosis J Clin Invest 100 1475 1480 10.1172/JCI119668 1:CAS:528:DyaK2sXmt1Cqsb8%3D 9294113
12. M Arlot PJ Meunier G Boivin, et al. 2005 Differential effects of teriparatide and alendronate on bone remodeling in postmenopausal women assessed by histomorphometric parameters J Bone Miner Res 20 1244 1253 10.1359/JBMR.050309 1:CAS:528:DC%2BD2MXmsFyitLw%3D 15940379 (Pubitemid 40863814)
13. R Recker P Masarachia AC Santora, et al. 2005 Trabecular bone microarchitecture after alendronate treatment of osteoporotic women Curr Med Res Opin 21 185 194 10.1185/030079904X20259 1:CAS:528:DC%2BD2MXktFGrsLY%3D 15801989 (Pubitemid 40469895)
14. R Balena BC Toolan M Shea A Markatos ER Myers SC Lee EE Opas JG Seedor H Klein D Frankenfield, et al. 1993 The effects of 2-year treatment with the aminobisphosphonate alendronate on bone metabolism, bone histomorphometry, and bone strength in ovariectomized nonhuman primates J Clin Invest 92 6 2577 2586 10.1172/JCI116872 1:CAS:528:DyaK2cXmvFGmuw%3D%3D 8254015
15. M Arlot Y Jiang H Genant, et al. 2008 Histomorphometric and microCT analysis of bone biopsies from postmenopausal osteoporotic women treated with strontium ranelate J Bone Miner Res 23 2 215 222 10.1359/jbmr.071012 1:CAS:528:DC%2BD1cXhvVOhtr8%3D 17922612 (Pubitemid 351160035)
16. TC Brennan MS Rybchyn W Green S Atwa AD Conigrave RS Mason 2009 Osteoblasts play key roles in the mechanisms of action of strontium ranelate Brit L Pharmacol 157 7 1291 1300 10.1111/j.1476-5381.2009.00305.x 1:CAS:528:DC%2BD1MXhtVelt7fN
17. E Bonnelye A Chabadel F Saltel P Jurdic 2008 Dual Effect of strontium ranelate: stimulation of osteoblast differentiation and inhibition of osteoclast formation and resorption in vitro Bone 42 129 138 10.1016/j.bone.2007.08.043 1:CAS:528:DC%2BD2sXhsVOrtr3E 17945546 (Pubitemid 350297175)
18. N Chattopadhyay SJ Quinn O Kifor C Ye EM Brown 2007 The calcium-sensing receptor (CaR) is involved in strontium ranelate-induced osteoblast proliferation Biochem Pharmacol 74 3 438 447 10.1016/j.bcp.2007.04.020 1:CAS:528:DC%2BD2sXntFamurs%3D 17531955 (Pubitemid 46970843)
19. GJ Atkins KJ Welldon P Halbout DM Findlay 2009 Strontium ranelate treatment of human primary osteoblasts promotes an osteocyte-like phenotype while eliciting an osteoprotegerin response Osteoporos Int 20 653 664 10.1007/s00198-008-0728-6 1:CAS:528:DC%2BD1MXis1Glurs%3D 18763010
20. SD Bain C Jerome V Shen I Dupin-Roger P Ammann 2009 Strontium ranelate improves bone strength in ovariectomized rat by positively influencing bone resistance determinants Osteoporos Int 20 8 1417 1428 10.1007/s00198-008-0815-8 1:CAS:528:DC%2BD1MXotlyhurg%3D 19096745
21. PJ Meunier C Roux E Seeman, et al. 2004 The effects of strontium ranelate on the risk of vertebral fracture in women with postmenopausal osteoporosis N Engl J Med 350 5 459 468 10.1056/NEJMoa022436 1:CAS:528:DC%2BD2cXos1Snsw%3D%3D 14749454 (Pubitemid 38133766)
22. JY Reginster E Seeman C De Vernejoul, et al. 2005 Strontium ranelate reduces the risk of nonvertebral fractures in postmenopausal women with osteoporosis: treatment of peripheral osteoporosis (TROPOS) study J Clin Endocrinol Metab 90 5 2816 2822 10.1210/jc.2004-1774 1:CAS:528: DC%2BD2MXkt1Wgt78%3D 15728210 (Pubitemid 40686329)
23. D Black S Cummings D Karpf, et al. 1996 Randomised trial of effects of alendronate on risk of fracture in women with existing vertebral fractures Lancet 348 1535 1541 10.1016/S0140-6736(96)07088-2 1:CAS:528: DyaK2sXisFCktQ%3D%3D 8950879 (Pubitemid 26411651)
24. A Laib HJ Hauselmann P Ruegsegger 1998 In vivo resolution 3D-QCT of the human forearm Thechnol Health Care 6 329 337 1:STN:280:DyaK1M7pvFSgtw%3D%3D
25. Boivin G, Farlay D, Khebbab MT, Jaurand X, Delmas PD, Meunier PJ (2009) In osteoporotic women treated with strontium ranelate, strontium is located in bone formed during treatment with a maintained degree of mineralization. Osteoporos Int 2010 Apr; 21(4):667-677
26. G Boivin PJ Meunier 2003 The mineralization of bone tissue: a forgotten dimension in osteoporosis research Osteoporos Int 14 Suppl 3 S19 S24 12730799
27. G Boivin P Chavassieux AC Santora 2000 Alendronate increases bone strength by increasing the mean degree of mineralization of bone tissue in osteoporotic women Bone 27 687 694 10.1016/S8756-3282(00)00376-8 1:CAS:528:DC%2BD3cXosFygtL8%3D 11062357
28. KA Davis AJ Burghardt TM Link S Majumdar 2007 The effects of geometric and threshold definitions on cortical bone metrics assessed by in vivo high-resolution peripheral quantitative computed tomography Calcif Tissue Int 81 364 371 10.1007/s00223-007-9076-3 1:CAS:528:DC%2BD2sXht1Oks77K 17952361 (Pubitemid 350077204)
29. P Garnero W Shih E Gineyts D Karpf P Delmas 1994 Comparison of new biochemical markers of bone turnover in late postmenopausal osteoporotic women in response to alendronate treatment J Clin Endocrinol Metab 79 6 1693 1700 10.1210/jc.79.6.1693 1:CAS:528:DyaK2MXislWiuro%3D 7989477